Screener
Tyra Biosciences, Inc. TYRA Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Tyra Biosciences, Inc.’s reported figures.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
FAQ
- What is Tyra Biosciences, Inc.'s invested capital?
- Tyra Biosciences, Inc. (TYRA) reported invested capital of $308.32M in Q1 2026.
- How has Tyra Biosciences, Inc.'s invested capital changed year-over-year?
- Tyra Biosciences, Inc.'s invested capital increased by 34.7% year-over-year, from $228.94M to $308.32M.
- What is the long-term trend for Tyra Biosciences, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s invested capital has grown at a 45.6% compound annual growth rate (CAGR), from -$28.71M to $187.6M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Tyra Biosciences, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude